Topical Everolimus in Patients With Tuberous Sclerosis Complex

首次发布于 2016 年 8 月 9 日

Tuberous Sclerosis Complex: Facial Angiofibroma Skin Cream

计划入组 11 人 · 首次发布于 2013 年 5 月 15 日

Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex

计划入组 24 人 · 首次发布于 2017 年 12 月 6 日

gene therapy (tuberous sclerosis)

Tuberous Sclerosis Complex(Quiver Bioscience)

Undisclosed,Q-State Biosciences Inc(TSC2,Tuberous Sclerosis Complex,Small Molecule)

Facial Concepts, Inc.

United States

National Multiple Sclerosis Society

United States

MULTIPLE SCLEROSIS CENTER OF CALIFORNIA

United States

AFT Pharmaceuticals Secures FDA Tentative Approval for Scomara in Facial Angiofibromas, US Launch Delayed Until 2029

U.S. Tuberous Sclerosis Drug Market Projected to Reach $1.25 Billion by 2030, Growing at 23.1% CAGR

Cannabidiol linked to better social, executive function in tuberous sclerosis complex